Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients
- PMID: 2203301
- PMCID: PMC171756
- DOI: 10.1128/AAC.34.6.1048
Investigation of potential interaction of ciprofloxacin with cyclosporine in bone marrow transplant recipients
Abstract
The effect of the 4-quinolone antimicrobial agent ciprofloxacin on the concentration in plasma and the pharmacokinetics of the immunosuppressive agent cyclosporine was studied in 10 bone marrow transplant recipients. There were no statistically or clinically significant changes in cyclosporine trough concentrations or areas under the concentration-time curve following oral doses of 500 mg of ciprofloxacin every 12 h for 4 days. The data suggest a lack of relevant pharmacokinetic interaction of ciprofloxacin with cyclosporine. There was no indication of an enhanced nephrotoxicity for this drug combination.
Similar articles
-
Cyclosporine (cyclosporin A) pharmacokinetics in renal transplant patients receiving ciprofloxacin.Am J Med. 1989 Nov 30;87(5A):82S-85S. doi: 10.1016/0002-9343(89)90029-6. Am J Med. 1989. PMID: 2589391
-
An evaluation of cyclosporine monitoring by nonselective fluorescence polarization immunoassay.Transplant Proc. 1990 Jun;22(3):1171-4. Transplant Proc. 1990. PMID: 2190376 No abstract available.
-
Japanese conference on cyclosporine blood level monitoring.Transplant Proc. 1990 Jun;22(3):1224-5. Transplant Proc. 1990. PMID: 2190384 No abstract available.
-
Does ciprofloxacin interact with cyclosporine?Ann Pharmacother. 1994 Jan;28(1):93-6. doi: 10.1177/106002809402800117. Ann Pharmacother. 1994. PMID: 8123970 Review.
-
Cyclosporine.South Med J. 1986 Feb;79(2):205-14. doi: 10.1097/00007611-198602000-00017. South Med J. 1986. PMID: 2418510 Review.
Cited by
-
Drug interactions with quinolone antibacterials.Drug Saf. 1992 Jul-Aug;7(4):268-81. doi: 10.2165/00002018-199207040-00003. Drug Saf. 1992. PMID: 1524699 Review.
-
Mediastinitis due to Nocardia asteroides after cardiac transplantation.Intensive Care Med. 1992;18(2):127-8. doi: 10.1007/BF01705048. Intensive Care Med. 1992. PMID: 1613194
-
Clinically significant drug interactions with cyclosporin. An update.Clin Pharmacokinet. 1996 Feb;30(2):141-79. doi: 10.2165/00003088-199630020-00004. Clin Pharmacokinet. 1996. PMID: 8906896 Review.
-
Clinical features and management of adverse effects of quinolone antibacterials.Drug Saf. 1991 Jan-Feb;6(1):8-27. doi: 10.2165/00002018-199106010-00002. Drug Saf. 1991. PMID: 2029356 Review.
-
Clinically significant interactions with drugs used in the treatment of tuberculosis.Drug Saf. 2002;25(2):111-33. doi: 10.2165/00002018-200225020-00005. Drug Saf. 2002. PMID: 11888353 Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical